In NSCLC, elevated IL-8 levels are associated with treatment resistance, with data from The Cancer Genome Atlas (TCGA) dataset showing a negative prognostic impact of high IL-8 levels in lung cancer, particularly in patients treated with chemotherapy and/or immunotherapy [128,178]. Here, CXCL8 is linked to lung carcinoma.